Friday, July 12, 2024 We are honored to be part of the California State Fair Cannabis Awards & Exhibit again this year! Our Founder and Managing Partner Omar Figueroa is an official CA State Fair Cannabis Ambassador, and both Omar and Lauren spoke at the inaugural CA State Fair […]
Read More
by Omar Figueroa & Lauren Mendelsohn July 9, 2024 California has been at the forefront of psychedelic policy change for years. In 2019, the City of Oakland became “the first in the nation to decriminalize a wide range of psychedelics such as psilocybin mushrooms and ayahuasca.” Similarly, in early 2020, […]
Read More
The Law Offices of Omar Figueroa is proud to announce that our Founder and Managing Partner Omar Figueroa, and our Junior Partner Lauren Mendelsohn, have been named Super Lawyers honorees again this year, and were included in the prestigious 2024 Northern California Super Lawyers list. Both Omar and Lauren have […]
Read More
By Lauren Mendelsohn and Omar Figueroa May 21, 2024 Today, the United States Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) officially posted the Notice of Proposed Rulemaking (NPRM) of the intent to reclassify cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). […]
Read More
by Omar Figueroa and Lauren Mendelsohn May 16, 2024 On May 16, 2024, the Biden Administration announced that the United States Department of Justice is taking the next step in the reclassification of cannabis from a Schedule I controlled substance to a Schedule III controlled substance — which would […]
Read More
By Lauren Mendelsohn May 10, 2024 Sonoma County recently approved its first round of grants under its local cannabis equity program, totaling $635,000 to 20 approved equity grant applicants. This comes after Sonoma County received a $687,561 grant from the Governor’s Office of Business and Economic Development (GO-Biz) […]
Read More
by Omar Figueroa & Lauren Mendelsohn May 6, 2024 In recent years, the U.S. government has introduced several measures to combat illicit financial activities, with the Corporate Transparency Act (CTA) of 2019 being one of the most significant. Aimed at enhancing transparency within legal entities such as corporations and […]
Read More
by Omar Figueroa & Lauren Mendelsohn May 2, 2024 We recently wrote that the Drug Enforcement Administration will move to reclassify marijuana as a Schedule III controlled substance. A recent update by the Congressional Research Service makes clear that rescheduling is predicted to result in significant federal tax relief […]
Read More
by Omar Figueroa & Lauren Mendelsohn May 1, 2024 Yesterday, we wrote that the Drug Enforcement Administration is anticipated to support the reclassification of marijuana from a Schedule I to a Schedule III controlled substance. Today, the Congressional Research Service issued an updated report on the Legal Consequences of Rescheduling […]
Read More
by Omar Figueroa and Lauren Mendelsohn April 30, 2024 On April 30, 2024, the Associated Press reported that the “U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug.” The proposal would “not legalize marijuana outright for recreational use” but “would move marijuana from its current […]
Read More